Ballentine Partners’s West Pharmaceutical WST Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-1,346	Closed	-$301K	–	1073
2025 Q1	$301K	Buy	1,346 +445	+49%	+$123K	0.01%	626
2024 Q4	$295K	Buy	901 +135	+18%	+$42.5K	0.01%	596
2024 Q3	$230K	Buy	766 +24	+3%	+$7.35K	﹤0.01%	699
2024 Q2	$244K	Buy	742 +33	+5%	+$11.7K	﹤0.01%	621
2024 Q1	$281K	Sell	709 -31	-4%	-$11.5K	0.01%	553
2023 Q4	$261K	Sell	740 -193	-21%	-$68.3K	0.01%	546
2023 Q3	$350K	Buy	933 +19	+2%	+$7.35K	0.01%	400
2023 Q2	$350K	Sell	914 -1	-0.1%	-$357	0.01%	409
2023 Q1	$317K	Buy	+915	New	+$267K	0.01%	403
2022 Q2	–	Sell	-658	Closed	-$270K	–	490
2022 Q1	$270K	Buy	658 +158	+32%	+$61.9K	0.01%	373
2021 Q4	$235K	Buy	+500	New	+$215K	0.01%	416